BP002122-PRO-1080: Recombinant Human Amyloid beta (A4) Precursor Protein (APP)
Source: E. Coli-derived.
Purity: > 85.0% as determined by SDS-PAGE.C124P: Lecanemab Biosimilar, Human amyloid-beta Monoclonal Antibody
Recombinant Humanized IgG1 kappa Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade lecanemab biosimilar specifically binds to the amyloid-beta protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by lecanemab.